Institute of Plant-Based Medicine
901 Dover Drive · Newport Beach, CA 92660
Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.
901 Dover Drive · Newport Beach, CA 92660
355 Placentia Avenue · Newport Beach, CA 92663
4.8(654 Google reviews · 49 in past year)
2801 East Coast Highway · Newport Beach, CA 92625
4.8(454 Google reviews · 70 in past year)
4440 Von Karman Avenue · Newport Beach, CA 92660
4.9(418 Google reviews · 85 in past year)
23 Corporate Plaza Drive · Newport Beach, CA 92660
5.0(298 Google reviews · 18 in past year)
4501 Birch Street · Newport Beach, CA 92660
4.9(89 Google reviews · 4 in past year)
2549 Eastbluff Drive · Newport Beach, CA 92660
5.0(78 Google reviews · 35 in past year)
4930 Campus Drive · Newport Beach, CA 92660
5.0(76 Google reviews)
1901 Westcliff Dr, Suite 10 · Newport Beach, CA 92660
5.0(66 Google reviews · 60 in past year)
4667 Macarthur Boulevard · Newport Beach, CA 92660
4.7(51 Google reviews · 16 in past year)
3 Corporate Plaza Drive · Newport Beach, CA 92660
4.8(36 Google reviews · 1 in past year)
4695 Macarthur Court · Newport Beach, CA 92660
5.0(31 Google reviews · 3 in past year)
2372 Southeast Bristol Street · Newport Beach, CA 92660
5.0(19 Google reviews · 9 in past year)
100 West Coast Hwy #105 · Newport Beach, CA 92663
5.0(14 Google reviews · 1 in past year)
833 Dover Drive · Newport Beach, CA 92663
5.0(14 Google reviews · 1 in past year)
20072 Southwest Birch Street · Newport Beach, CA 92660
5.0(8 Google reviews · 6 in past year)
Pins reflect street addresses where available; others are approximate (ZIP-level).
No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Newport Beach or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.
They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.
Yes — 5 of the 20 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve California residents; confirm with the practice.
No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.
Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.